Gamut Therapeutics Overview
- Year Founded
-
2020
- Status
-
Private
- Latest Deal Type
-
M&A
Gamut Therapeutics General Information
Description
Developer of a gene therapy approach in ophthalmology intended to treat retinitis pigmentosa.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
- 4 Rue Thenard
- 75005 Paris
- France
Corporate Office
- 4 Rue Thenard
- 75005 Paris
- France
Gamut Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 20-Apr-2021 | Completed | Startup | |||
| 2. Early Stage VC | 03-Feb-2021 | Completed | Startup | |||
| 1. Seed Round | 01-Oct-2020 | Completed | Startup |
Gamut Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| ABSA |
Gamut Therapeutics FAQs
-
When was Gamut Therapeutics founded?
Gamut Therapeutics was founded in 2020.
-
Where is Gamut Therapeutics headquartered?
Gamut Therapeutics is headquartered in Paris, France.
-
What industry is Gamut Therapeutics in?
Gamut Therapeutics’s primary industry is Drug Discovery.
-
Is Gamut Therapeutics a private or public company?
Gamut Therapeutics is a Private company.
-
What is Gamut Therapeutics’s current revenue?
The current revenue for Gamut Therapeutics is .
-
How much funding has Gamut Therapeutics raised over time?
Gamut Therapeutics has raised $1.22M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process